The movement disorder society criteria for the diagnosis of multiple system atrophy
GK Wenning, I Stankovic, L Vignatelli… - Movement …, 2022 - Wiley Online Library
Background The second consensus criteria for the diagnosis of multiple system atrophy
(MSA) are widely recognized as the reference standard for clinical research, but lack …
(MSA) are widely recognized as the reference standard for clinical research, but lack …
Neuropathology and molecular diagnosis of Synucleinopathies
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized
by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies …
by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies …
Clinical neurology and epidemiology of the major neurodegenerative diseases
MG Erkkinen, MO Kim… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …
older adults. Most clinicians who care for the elderly are not trained to diagnose these …
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
allows to assess several cortical properties such as excitability, plasticity and connectivity in …
Multiple-system atrophy
A Fanciulli, GK Wenning - New England Journal of Medicine, 2015 - Mass Medical Soc
Multiple-system atrophy is a neurodegenerative disease characterized by progressive
autonomic failure, parkinsonism, and cerebellar and pyramidal tract symptoms. Glial …
autonomic failure, parkinsonism, and cerebellar and pyramidal tract symptoms. Glial …
Multiple system atrophy: an oligodendroglioneural synucleinopathy
KA Jellinger - Journal of Alzheimer's Disease, 2018 - content.iospress.com
Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …
uncertain etiology that is clinically characterized by various combinations of parkinsonism …
Diagnosis of multiple system atrophy
JA Palma, L Norcliffe-Kaufmann, H Kaufmann - Autonomic Neuroscience, 2018 - Elsevier
Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …
particularly in the early stages of the disease. An autonomic-only presentation can be …
Expanding the spectrum of neuronal pathology in multiple system atrophy
MD Cykowski, EA Coon, SZ Powell, SM Jenkins… - Brain, 2015 - academic.oup.com
Multiple system atrophy is a sporadic alpha-synucleinopathy that typically affects patients in
their sixth decade of life and beyond. The defining clinical features of the disease include …
their sixth decade of life and beyond. The defining clinical features of the disease include …
Multiple system atrophy: insights into a rare and debilitating movement disorder
F Krismer, GK Wenning - Nature Reviews Neurology, 2017 - nature.com
Multiple system atrophy (MSA) is a devastating and fatal neurodegenerative disorder. The
clinical presentation of this disease is highly variable, with parkinsonism, cerebellar ataxia …
clinical presentation of this disease is highly variable, with parkinsonism, cerebellar ataxia …